Exelixis
EXEL
#1347
Rank
A$23.82 B
Marketcap
A$97.64
Share price
-1.82%
Change (1 day)
49.44%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Earnings for Exelixis (EXEL)

Earnings in 2026 (TTM): A$1.55 Billion

According to Exelixis's latest financial reports the company's current earnings are A$2.49 Billion. In 2025 the company made an earning of A$1.42 Billion, an increase over its 2024 earnings that were of A$1.02 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exelixis from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$1.55 B9.09%
2025 A$1.42 B38.08%
2024 A$1.02 B164.69%
2023 A$0.38 B9.89%
2022 A$0.35 B-20.33%
2021 A$0.44 B124.82%
2020 A$0.19 B-67.14%
2019 A$0.60 B-11.94%
2018 A$0.68 B185.09%
2017 A$0.23 B-325.82%
2016 -A$0.11 Billion-58.12%
2015 -A$0.26 Billion-37.61%
2014 -A$0.41 Billion9.75%
2013 -A$0.37 Billion65.96%
2012 -A$0.23 Billion-291.63%
2011 A$0.11 B-195.59%
2010 -A$0.13 Billion-42.17%
2009 -A$0.22 Billion-18.98%
2008 -A$0.26 Billion-6.99%
2007 -A$0.28 Billion46.3%
2006 -A$0.2 Billion33.25%
2005 -A$0.15 Billion-30.92%
2004 -A$0.21 Billion44.29%
2003 -A$0.15 Billion12.86%
2002 -A$0.13 Billion22.79%
2001 -A$0.11 Billion60.14%
2000 -A$64.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$28.28 B 1,656.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$10.52 B 553.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.69 B 936.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$11.76 B 630.69%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$10.15 B 530.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.12 B 963.20%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$10.80 B 571.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-A$12.77 Million-100.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-A$43.88 Million-102.72%๐Ÿ‡บ๐Ÿ‡ธ USA